Coulter Partners provides leadership consultancy to Life Sciences, Health and Technology innovation businesses globally. We build teams that change the world and create a better future. Over 20 years we have delivered on 1000s of assignments across the USA, Canada, UK/Europe, and APAC, advising companies and investors on how to shape and hire their boards and leadership teams. We strongly impact value and growth. Our 110 experts operate uniquely as one global team. With our track record, AI, bespoke systems and wealth of data, we fuel the ability of investors, boards and executive teams to deliver value from innovation.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life science organizations have been turning to executive search firms more than ever to acquire world-class leadership. Life sciences recruiting specialist Coulter Partners recently assisted in the recruitment of Wei Chen and Daisy Chhokar as the first chief scientific officer and chief people officer, respectively, at drug discovery company Totus Medicines. “The next few years will be pivotal for
Since the pandemic appeared nearly two years ago, numerous healthcare organizations and companies have turned to executive search firms to find new chief medical officers. In the era of COVID-19 it is just another burgeoning area for executive search firms. Life sciences recruiting specialist Coulter Partners recently assisted in the recruitment of Sanjay Aggarwal as chief medical officer
Over the past few months, numerous healthcare organizations have turned to executive search firms to find new chief medical officers. In the era of COVID-19 this is likely to be another burgeoning area for executive search firms. Life sciences search specialist Coulter Partners recently assisted in the recruitment of Antonio Speziale as the first chief medical officer
Life sciences search specialist Coulter Partners has expanded with the addition of Christelle Kerouedan as marketing director. “We are delighted to welcome Christelle to the team and are looking forward to working with her on the next phase of development of Coulter Partners,” said CEO Bianca Coulter. Her extensive experience as a life sciences communications specialist will
London, 10 February 2022 – Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, has appointed four young professionals in the US and nine at its London headquarters in the last 12 months, concluding an extremely successful 2021 and looking forward to a very exciting 2022. Liam
(Nov. 10, 2021) Coulter Partners was pleased to partner recently with Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, to secure the appointment of Antonio Speziale as Chief Medical Officer. Antonio will lead Enthera’s clinical team as they advance the Company’s
(Sept. 23, 2021) Coulter Partners, a global Life Sciences, Health and Technology executive search specialist, today announces the appointment of Dr Christelle Kerouedan as Marketing Director. Christelle’s career has been dedicated to the Life Sciences and Technology sectors with experience gained in academia, start-ups, and communications agencies over the last 24 years. She combines strong marketing
(Sept. 21, 2021) Coulter Partners, a global Life Sciences, Health and Technology executive search specialist, was delighted to partner with Civetta Therapeutics, LLC, a biotechnology company focused on developing a pipeline of therapies that target beta-propeller proteins, to secure the appointment of Christopher D. Roberts, Ph.D., as Chief Executive Officer. Dr. Roberts, who most recently
(July 2021) Coulter Partners was very pleased to partner recently with Memo Therapeutics AG, an innovator in the field of antibody discovery and development, to secure the appointment of Dr. George Badita as Chief Medical Officer. Dr. Badita is an MD, board certified in Infectious Diseases, with over 30 years of experience in life sciences
Blogs
D, E & I: VIEWS FROM LEADERSHIP SERIES – Lene Gerlach, Founder and Chair of Women in Life Science Denmark (WiLD), and Partner at Eir Ventures
D, E & I: VIEWS FROM LEADERSHIP SERIES – Yael Gruenbaum-Cohen, Partner at aMoon and Founder of WE@HealthTech
Top hires for VC & PE portfolio companies Q4-2023
Top global hires for large-cap, mid-cap and public companies H2-2023
Top hires for VC & PE portfolio companies Q3-2023
Top hires for VC & PE portfolio companies Q2-2023
Top global hires for large-cap, mid-cap and public companies H1-2023
Top hires for VC & PE portfolio companies Q1-2023
D, E & I: Views From Leadership Series – Charlotte Valeur, Founder of Institute Of Neurodiversity, ION
Top hires for VC & PE portfolio companies Q4-2022
Top global hires for large-cap, mid-cap and public companies H2-2022
Diversity, Equity, & Inclusion: Views From Leadership Series- Quita Highsmith, Vice President and Chief Diversity Officer at Genentech
Diversity, Equity & Inclusion: Views from Leadership-Tomoko Adachi
Diversity, Equity & Inclusion: Views from Leadership-Corinne Le Goff